In conclusion, our study provides a novel and significant information about the role CCR4 during CHB infection and demonstrate that CCR4 is a major player in HBV-specific T cell immune dysfunction in CHB patients and its blockade recovers various levels of immune dysfunction such as cell proliferation, antiviral cytokine secretion and cytotoxic T cell functions. The gene discussed is CCR4; the disease is immune system disorder.